| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | H1-10 H3-5 CGAS SAP30L POU4F1 MED1 MECP2 AHDC1 HNRNPC MEOX1 CRX MSH6 TNRC18 THRA TOX3 H3-3A CHD6 VCX TOP2B | 1.75e-08 | 739 | 109 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 3.36e-07 | 167 | 109 | 9 | GO:0031490 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 1.25e-06 | 100 | 109 | 7 | GO:0030527 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.61e-05 | 98 | 109 | 6 | GO:0031491 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.97e-05 | 127 | 109 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | helicase activity | 2.31e-04 | 158 | 109 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | histone reader activity | 3.75e-04 | 26 | 109 | 3 | GO:0140566 | |
| GeneOntologyMolecularFunction | DNA insertion or deletion binding | 4.37e-04 | 6 | 109 | 2 | GO:0032135 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 4.94e-04 | 67 | 109 | 4 | GO:0031492 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B ATP10A MSH6 DDX46 IGHMBP2 RECQL5 DDX23 MACF1 CHD6 XRCC6 TOP2B | 5.34e-04 | 614 | 109 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | cadherin binding | 5.46e-04 | 339 | 109 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.00e-04 | 441 | 109 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DIS3L2 MSH6 DDX46 PDE12 IGHMBP2 RECQL5 POP1 DDX23 CHD6 XRCC6 TOP2B | 8.01e-04 | 645 | 109 | 11 | GO:0140640 |
| GeneOntologyMolecularFunction | transcription factor binding | POU4F1 XPC MED1 MECP2 CRX THRA IGHMBP2 SORBS3 CHD6 UHRF2 FOXF2 BRMS1 | 8.35e-04 | 753 | 109 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | structural molecule activity | H1-10 H3-5 ANK2 LAMC3 H3-4 H3-7 H3C15 MAGI2 H3C1 SORBS3 MACF1 H3-3A CTNNA1 | 1.14e-03 | 891 | 109 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 1.45e-03 | 41 | 109 | 3 | GO:0140463 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 1.45e-03 | 41 | 109 | 3 | GO:0000217 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | IRF2BP2 ANK2 CGAS SAP30L XPC SSX8P MED1 BCL9 MECP2 HNRNPC PHF2 MAGI2 MDC1 TOX3 HDGFL2 | 1.58e-03 | 1160 | 109 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | vinculin binding | 2.21e-03 | 13 | 109 | 2 | GO:0017166 | |
| GeneOntologyMolecularFunction | mismatched DNA binding | 2.57e-03 | 14 | 109 | 2 | GO:0030983 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | IRF2BP2 ANK2 CGAS SAP30L XPC SSX8P MED1 BCL9 MECP2 AHDC1 HNRNPC PHF2 MAGI2 MDC1 TOX3 HDGFL2 | 2.78e-03 | 1356 | 109 | 16 | GO:0060090 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | CDKN1C H1-10 ACTR8 HIRIP3 MED1 H3-4 H3C15 MECP2 HNRNPC PRDM2 PHF2 THRA H3C1 MDC1 DDX23 H3-3A CHD6 UHRF2 HDGFL2 VCX | 1.82e-07 | 999 | 107 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | CDKN1C H1-10 ACTR8 HIRIP3 H3-4 H3C15 MECP2 HNRNPC PRDM2 PHF2 H3C1 MDC1 DDX23 H3-3A CHD6 UHRF2 HDGFL2 VCX | 7.74e-07 | 896 | 107 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | CDKN1C H1-10 ACTR8 H3-4 H3C15 MECP2 HNRNPC PRDM2 PHF2 H3C1 DDX23 H3-3A CHD6 UHRF2 HDGFL2 | 6.51e-06 | 741 | 107 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | CDKN1C IRF2BP2 TRO SAP30L POU4F1 POU6F1 MED1 MECP2 PRDM2 ZNF512B IFNG THRA ZNF608 IGHMBP2 SORBS3 NOTCH3 FOXF1 BRMS1 | 7.48e-06 | 1053 | 107 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | CDKN1C IRF2BP2 TRO SAP30L POU4F1 POU6F1 MED1 MECP2 PRDM2 ZNF512B IFNG THRA ZNF608 IGHMBP2 RECQL5 SORBS3 XRCC6 NOTCH3 FOXF1 FOXF2 BRMS1 | 8.79e-06 | 1399 | 107 | 21 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | CDKN1C IRF2BP2 TRO SAP30L POU4F1 POU6F1 MED1 MECP2 PRDM2 ZNF512B IFNG THRA ZNF608 IGHMBP2 RECQL5 SORBS3 XRCC6 NOTCH3 FOXF1 FOXF2 BRMS1 | 1.02e-05 | 1413 | 107 | 21 | GO:1902679 |
| GeneOntologyBiologicalProcess | DNA recombination | 1.28e-04 | 368 | 107 | 9 | GO:0006310 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 1.32e-04 | 150 | 107 | 6 | GO:0000018 | |
| GeneOntologyCellularComponent | chromatin | H1-10 ACTR8 H3-5 SAP30L POU4F1 XPC POU6F1 MED1 H3-4 H3-7 H3C15 MECP2 HNRNPC MEOX1 CRX MEOX2 MSH6 THRA H3C1 DDX23 H3-3A CHD6 UHRF2 TOP2B FOXF1 FOXF2 BRMS1 | 6.80e-09 | 1480 | 109 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | nucleosome | 7.98e-06 | 138 | 109 | 7 | GO:0000786 | |
| Domain | HISTONE_H3_1 | 3.52e-08 | 7 | 107 | 4 | PS00322 | |
| Domain | HISTONE_H3_2 | 7.00e-08 | 8 | 107 | 4 | PS00959 | |
| Domain | Histone_H3/CENP-A | 7.00e-08 | 8 | 107 | 4 | IPR000164 | |
| Domain | H3 | 7.00e-08 | 8 | 107 | 4 | SM00428 | |
| Domain | VCX_VCY | 1.81e-06 | 5 | 107 | 3 | PF15231 | |
| Domain | VCX/VCY1 | 1.81e-06 | 5 | 107 | 3 | IPR026653 | |
| Domain | Alpha_catenin | 1.94e-04 | 4 | 107 | 2 | IPR001033 | |
| Domain | VINCULIN_1 | 1.94e-04 | 4 | 107 | 2 | PS00663 | |
| Domain | Vinculin_CS | 1.94e-04 | 4 | 107 | 2 | IPR000633 | |
| Domain | Histone_H2A/H2B/H3 | 2.97e-04 | 56 | 107 | 4 | IPR007125 | |
| Domain | Histone | 2.97e-04 | 56 | 107 | 4 | PF00125 | |
| Domain | Vinculin | 3.22e-04 | 5 | 107 | 2 | PF01044 | |
| Domain | HSR | 3.22e-04 | 5 | 107 | 2 | PS51414 | |
| Domain | HSR | 3.22e-04 | 5 | 107 | 2 | PF03172 | |
| Domain | HSR_dom | 3.22e-04 | 5 | 107 | 2 | IPR004865 | |
| Domain | DEXDc | 4.09e-04 | 109 | 107 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.27e-04 | 110 | 107 | 5 | IPR014001 | |
| Domain | - | 6.61e-04 | 69 | 107 | 4 | 1.10.20.10 | |
| Domain | Vinculin/catenin | 6.70e-04 | 7 | 107 | 2 | IPR006077 | |
| Domain | SAND_dom | 8.90e-04 | 8 | 107 | 2 | IPR000770 | |
| Domain | SAND | 8.90e-04 | 8 | 107 | 2 | PF01342 | |
| Domain | SAND | 8.90e-04 | 8 | 107 | 2 | PS50864 | |
| Domain | SAND | 8.90e-04 | 8 | 107 | 2 | SM00258 | |
| Domain | PHD | 9.05e-04 | 75 | 107 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 1.10e-03 | 79 | 107 | 4 | IPR019787 | |
| Domain | Histone-fold | 1.32e-03 | 83 | 107 | 4 | IPR009072 | |
| Domain | PHD | 1.71e-03 | 89 | 107 | 4 | SM00249 | |
| Domain | Znf_PHD | 1.86e-03 | 91 | 107 | 4 | IPR001965 | |
| Domain | - | 2.07e-03 | 12 | 107 | 2 | 3.10.390.10 | |
| Domain | SAND_dom-like | 2.07e-03 | 12 | 107 | 2 | IPR010919 | |
| Domain | ZF_PHD_2 | 2.17e-03 | 95 | 107 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.26e-03 | 96 | 107 | 4 | PS01359 | |
| Domain | Helicase_C | 3.34e-03 | 107 | 107 | 4 | PF00271 | |
| Domain | HELICc | 3.34e-03 | 107 | 107 | 4 | SM00490 | |
| Domain | Helicase_C | 3.46e-03 | 108 | 107 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 3.57e-03 | 109 | 107 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.57e-03 | 109 | 107 | 4 | PS51192 | |
| Domain | POU | 3.70e-03 | 16 | 107 | 2 | SM00352 | |
| Domain | POU_dom | 3.70e-03 | 16 | 107 | 2 | IPR000327 | |
| Domain | Pou | 3.70e-03 | 16 | 107 | 2 | PF00157 | |
| Domain | POU_1 | 3.70e-03 | 16 | 107 | 2 | PS00035 | |
| Domain | POU_2 | 3.70e-03 | 16 | 107 | 2 | PS00465 | |
| Domain | POU_3 | 3.70e-03 | 16 | 107 | 2 | PS51179 | |
| Domain | POU | 4.18e-03 | 17 | 107 | 2 | IPR013847 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGH_MMSET_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 6.83e-08 | 19 | 83 | 5 | M47442 | |
| Pathway | REACTOME_SUMOYLATION | 6.07e-05 | 169 | 83 | 7 | MM14919 | |
| Pathway | REACTOME_SUMOYLATION | 1.22e-04 | 189 | 83 | 7 | M27214 | |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | 1.67e-04 | 139 | 83 | 6 | M4741 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.96e-04 | 91 | 83 | 5 | M27101 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGEF18 CDCA8 H3C15 HNRNPC ZNF512B H3C1 FAM13A VANGL1 ARHGEF1 BTK H3-3A CTNNA1 GOLGA3 | 2.79e-04 | 720 | 83 | 13 | M41838 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | IRF2BP2 H1-10 PPAN SRSF6 HIRIP3 SAP30L TATDN2 XPC GPATCH8 MED1 BCL9 MECP2 HNRNPC PRDM2 PCF11 MSH6 DDX46 FAM13A MDC1 POP1 SORBS3 AFF1 SCAF11 CTNNA1 XRCC6 TOP2B | 3.02e-19 | 774 | 113 | 26 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | H1-10 ACTR8 SRSF6 HIRIP3 SAP30L LRRC59 XPC GPATCH8 MED1 SP110 MECP2 AHDC1 HNRNPC PRDM2 ZNF512B PHF2 DDX46 H3C1 FBXO28 RECQL5 MDC1 POP1 DDX23 SCAF11 CHD6 HDGFL2 XRCC6 TOP2B BRMS1 | 9.80e-17 | 1294 | 113 | 29 | 30804502 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIRIP3 LRRC59 XPC GPATCH8 MED1 CDCA8 MECP2 PRDM2 ZNF512B PHF2 MSH6 RECQL5 MDC1 H3-3A SCAF11 CHD6 UHRF2 HDGFL2 XRCC6 TOP2B | 9.13e-15 | 608 | 113 | 20 | 36089195 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H1-10 H3-5 SRSF6 LRRC59 MED1 H3-4 CDCA8 H3C15 MECP2 HNRNPC ZNF512B PCF11 PHF2 DDX46 H3C1 RECQL5 MDC1 H3-3A SCAF11 HDGFL2 XRCC6 TOP2B | 4.78e-13 | 954 | 113 | 22 | 36373674 |
| Pubmed | PPAN H3-5 ANK2 NHSL2 TRO LRRC59 XPC H3-4 H3C15 MECP2 HNRNPC PCF11 TNRC18 H3C1 ZNF608 EFCAB12 DDX23 MACF1 H3-3A CHD6 HDGFL2 XRCC6 TOP2B | 2.19e-10 | 1442 | 113 | 23 | 35575683 | |
| Pubmed | EPS8 PPAN XPC GPATCH8 MED1 H3C15 MECP2 AHDC1 PCF11 PHF2 MSH6 DDX46 H3C1 VANGL1 FBXO28 IGHMBP2 RECQL5 MDC1 POP1 MACF1 SCAF11 CHD6 HDGFL2 | 4.52e-10 | 1497 | 113 | 23 | 31527615 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | H1-10 PPAN SRSF6 LRRC59 H3C15 HNRNPC ZNF512B MSH6 DDX46 MDC1 DDX23 SCAF11 HDGFL2 XRCC6 TOP2B | 1.28e-09 | 605 | 113 | 15 | 28977666 |
| Pubmed | H1-10 PPAN SRSF6 LRRC59 MED1 H3C15 MECP2 HNRNPC MSH6 POP1 DDX23 HDGFL2 XRCC6 | 2.24e-09 | 441 | 113 | 13 | 31239290 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | LRRC59 MED1 MECP2 PCF11 MSH6 DDX46 MDC1 SCAF11 HDGFL2 XRCC6 TOP2B | 2.38e-09 | 283 | 113 | 11 | 30585729 |
| Pubmed | 4.76e-09 | 74 | 113 | 7 | 36180920 | ||
| Pubmed | Crystal structure of DPF3b in complex with an acetylated histone peptide. | 1.31e-08 | 9 | 113 | 4 | 27402533 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRSF6 LRRC59 XPC GPATCH8 MED1 MECP2 AHDC1 HNRNPC ZNF512B PCF11 PHF2 MSH6 DDX46 DDX23 MACF1 CHD6 XRCC6 TOP2B | 1.35e-08 | 1082 | 113 | 18 | 38697112 |
| Pubmed | IRF2BP2 MED1 BCL9 AHDC1 ZNF512B PCF11 TNRC18 ZNF608 MDC1 BRMS1 | 1.93e-08 | 268 | 113 | 10 | 33640491 | |
| Pubmed | 3.43e-08 | 11 | 113 | 4 | 15471871 | ||
| Pubmed | Human PAD4 regulates histone arginine methylation levels via demethylimination. | 3.43e-08 | 11 | 113 | 4 | 15345777 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | H1-10 ACTR8 HIRIP3 XPC MED1 HNRNPC MDC1 POP1 DDX23 SCAF11 XRCC6 | 7.10e-08 | 394 | 113 | 11 | 27248496 |
| Pubmed | 1.03e-07 | 14 | 113 | 4 | 16267050 | ||
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 10903929 | ||
| Pubmed | 1.43e-07 | 251 | 113 | 9 | 31076518 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | H1-10 PPAN SRSF6 LRRC59 CDCA8 H3C15 HNRNPC ZNF512B DDX46 VANGL1 MDC1 DDX23 MACF1 CTNNA1 XRCC6 TOP2B | 2.18e-07 | 1024 | 113 | 16 | 24711643 |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9 AHDC1 PRDM2 CRX ZNF512B TNRC18 ZNF608 MDC1 CTNNA1 UHRF2 | 2.39e-07 | 351 | 113 | 10 | 38297188 |
| Pubmed | KIF21B EPS8 SRSF6 CGAS HNRNPC DDX46 H3C1 MDC1 DDX23 MACF1 HDGFL2 XRCC6 TOP2B | 2.49e-07 | 660 | 113 | 13 | 32780723 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | H1-10 PPAN SRSF6 CGAS LRRC59 HNRNPC PHF2 MSH6 DDX46 H3C1 ARHGEF1 BTK POP1 DDX23 H3-3A CHD6 XRCC6 TOP2B | 2.58e-07 | 1318 | 113 | 18 | 30463901 |
| Pubmed | H1-10 SRSF6 ANK2 LRRC59 ZNF512B PCF11 PDE12 H3C1 VANGL1 POP1 C1orf52 DDX23 MACF1 CTNNA1 OCLN HDGFL2 GOLGA3 XRCC6 TOP2B | 3.19e-07 | 1487 | 113 | 19 | 33957083 | |
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 7309716 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 10607842 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 16185088 | ||
| Pubmed | IRF2BP2 MED1 BCL9 MECP2 AHDC1 PRDM2 PCF11 PHF2 MSH6 TNRC18 C1orf52 DDX23 H3-3A UHRF2 XRCC6 TOP2B | 5.84e-07 | 1103 | 113 | 16 | 34189442 | |
| Pubmed | Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. | 6.06e-07 | 21 | 113 | 4 | 11242053 | |
| Pubmed | 6.63e-07 | 6 | 113 | 3 | 10464286 | ||
| Pubmed | Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. | 6.63e-07 | 6 | 113 | 3 | 15525939 | |
| Pubmed | Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. | 6.63e-07 | 6 | 113 | 3 | 12560483 | |
| Pubmed | Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification. | 6.63e-07 | 6 | 113 | 3 | 17189264 | |
| Pubmed | Organismal differences in post-translational modifications in histones H3 and H4. | 6.63e-07 | 6 | 113 | 3 | 17194708 | |
| Pubmed | H1-10 ACTR8 SAP30L XPC PPFIA3 SP110 MECP2 ZNF512B PHF2 MSH6 THRA ZNF608 VANGL1 MACF1 H3-3A SP140 | 6.81e-07 | 1116 | 113 | 16 | 31753913 | |
| Pubmed | H1-10 PPAN SRSF6 LRRC59 XPC AHDC1 HNRNPC ZNF512B PCF11 DDX46 MDC1 POP1 SCAF11 TOP2B | 6.85e-07 | 847 | 113 | 14 | 35850772 | |
| Pubmed | 8.28e-07 | 156 | 113 | 7 | 37108203 | ||
| Pubmed | IRF2BP2 H1-10 ACTR8 PPAN LRRC59 GPATCH8 BCL9 PRDM2 ZNF512B PCF11 PHF2 ZNF608 RECQL5 MDC1 SCAF11 CHD6 XRCC6 BRMS1 | 8.32e-07 | 1429 | 113 | 18 | 35140242 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | H1-10 POU4F1 POU6F1 MED1 ANKRD6 SP110 MECP2 MEOX1 MEOX2 ZNF512B PHF2 THRA ZNF556 TOX3 | 1.03e-06 | 877 | 113 | 14 | 20211142 |
| Pubmed | H3-5 SRSF6 HIRIP3 PPFIA3 H3-4 NUDT13 ZNF512B H3C1 MDC1 DDX23 CHD6 GOLGA3 XRCC6 | 1.11e-06 | 754 | 113 | 13 | 35906200 | |
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 15684425 | ||
| Pubmed | Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. | 1.16e-06 | 7 | 113 | 3 | 11856369 | |
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 20448663 | ||
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 15681610 | ||
| Pubmed | 1.16e-06 | 7 | 113 | 3 | 16497732 | ||
| Pubmed | HIRIP3 XPC MED1 CDCA8 MECP2 ZNF512B PHF2 H3C1 ZNF608 RECQL5 CHD6 XRCC6 | 1.34e-06 | 645 | 113 | 12 | 25281560 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 1.44e-06 | 59 | 113 | 5 | 28813667 | |
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 1.49e-06 | 26 | 113 | 4 | 30923192 | |
| Pubmed | H1-10 SRSF6 LRRC59 HNRNPC MSH6 TNRC18 DDX46 POP1 DDX23 CHD6 XRCC6 BRMS1 | 1.58e-06 | 655 | 113 | 12 | 35819319 | |
| Pubmed | H1-10 LRRC59 H3-4 H3C15 H3C1 MDC1 DDX23 H3-3A CTNNA1 HDGFL2 GOLGA3 XRCC6 TOP2B | 1.75e-06 | 786 | 113 | 13 | 29128334 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | H1-10 DIS3L2 SRSF6 CGAS XPC H3-7 HNRNPC MSH6 PDE12 ARHGEF1 RECQL5 MDC1 POP1 DDX23 MACF1 XRCC6 TOP2B | 1.80e-06 | 1353 | 113 | 17 | 29467282 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H1-10 H3-5 LRRC59 H3-4 H3-7 H3C15 HNRNPC DDX46 H3C1 MDC1 POP1 DDX23 CTNNA1 XRCC6 | 2.59e-06 | 949 | 113 | 14 | 36574265 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.93e-06 | 361 | 113 | 9 | 26167880 | |
| Pubmed | Human tNASP promotes in vitro nucleosome assembly with histone H3.3. | 3.11e-06 | 31 | 113 | 4 | 25615412 | |
| Pubmed | LRRC59 MED1 CDCA8 MECP2 HNRNPC NECAP1 PDE12 C1orf52 MACF1 HDGFL2 | 3.44e-06 | 472 | 113 | 10 | 38943005 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 4.97e-06 | 289 | 113 | 8 | 23752268 | |
| Pubmed | 5.08e-06 | 205 | 113 | 7 | 28927264 | ||
| Pubmed | IRF2BP2 LRRC59 GPATCH8 MED1 MSH6 DDX46 H3C1 MDC1 DDX23 H3-3A UHRF2 HDGFL2 XRCC6 TOP2B | 5.53e-06 | 1014 | 113 | 14 | 32416067 | |
| Pubmed | 6.34e-06 | 506 | 113 | 10 | 30890647 | ||
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 6.42e-06 | 37 | 113 | 4 | 36835656 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ARHGEF18 ATP10A AHDC1 HNRNPC PHF2 TNRC18 THRA FAM13A ZNF608 TOX3 AFF1 MACF1 SCAF11 CHD6 NOTCH3 PDZD2 BRMS1 | 6.43e-06 | 1489 | 113 | 17 | 28611215 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | H1-10 PPAN MED1 CDCA8 MSH6 DDX46 IGHMBP2 POP1 MACF1 SCAF11 XRCC6 TOP2B | 7.08e-06 | 759 | 113 | 12 | 35915203 |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 8.83e-06 | 85 | 113 | 5 | 16051665 | |
| Pubmed | A phospho/methyl switch at histone H3 regulates TFIID association with mitotic chromosomes. | 9.33e-06 | 13 | 113 | 3 | 20953165 | |
| Pubmed | H1-10 LRRC59 H3-7 H3C15 HNRNPC RECQL5 MDC1 DDX23 H3-3A XRCC6 TOP2B | 9.54e-06 | 652 | 113 | 11 | 31180492 | |
| Pubmed | 9.71e-06 | 419 | 113 | 9 | 15635413 | ||
| Pubmed | A unique H3K4me2 profile marks tissue-specific gene regulation. | 1.05e-05 | 2 | 113 | 2 | 20841431 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10822266 | ||
| Pubmed | The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. | 1.05e-05 | 2 | 113 | 2 | 12427740 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 34415548 | ||
| Pubmed | Structural studies of the SET domain from RIZ1 tumor suppressor. | 1.05e-05 | 2 | 113 | 2 | 18082620 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12368356 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28004105 | ||
| Pubmed | Differential localization of Mox-1 and Mox-2 proteins indicates distinct roles during development. | 1.05e-05 | 2 | 113 | 2 | 9032023 | |
| Pubmed | αE-catenin is an autoinhibited molecule that coactivates vinculin. | 1.05e-05 | 2 | 113 | 2 | 22586082 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 14745957 | ||
| Pubmed | Inactivation of a histone methyltransferase by mutations in human cancers. | 1.05e-05 | 2 | 113 | 2 | 14633678 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12051829 | ||
| Pubmed | Characterization of the PR domain of RIZ1 histone methyltransferase. | 1.05e-05 | 2 | 113 | 2 | 15964548 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30565344 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 39162523 | ||
| Pubmed | DmFoxF, a novel Drosophila fork head factor expressed in visceral mesoderm. | 1.05e-05 | 2 | 113 | 2 | 11804790 | |
| Pubmed | Differential activation of lung-specific genes by two forkhead proteins, FREAC-1 and FREAC-2. | 1.05e-05 | 2 | 113 | 2 | 8626802 | |
| Pubmed | 1.09e-05 | 425 | 113 | 9 | 21081503 | ||
| Pubmed | Notch signaling differentially regulates Atoh7 and Neurog2 in the distal mouse retina. | 1.18e-05 | 14 | 113 | 3 | 25100656 | |
| Pubmed | H1-10 PPAN SRSF6 LRRC59 MED1 AHDC1 HNRNPC TNRC18 H3C1 ZNF608 IGHMBP2 POP1 AFF1 CTNNA1 XRCC6 | 1.29e-05 | 1247 | 113 | 15 | 27684187 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 1.39e-05 | 333 | 113 | 8 | 32665550 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | H1-10 SRSF6 LRRC59 HNRNPC MSH6 DDX46 ARHGEF1 MDC1 POP1 DDX23 MACF1 SCAF11 CTNNA1 HDGFL2 XRCC6 TOP2B | 1.39e-05 | 1415 | 113 | 16 | 28515276 |
| Pubmed | 1.40e-05 | 159 | 113 | 6 | 22751105 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | H1-10 PPAN SRSF6 CGAS LRRC59 MECP2 HNRNPC MSH6 H3C1 MDC1 POP1 SCAF11 CTNNA1 UHRF2 XRCC6 | 1.42e-05 | 1257 | 113 | 15 | 36526897 |
| Pubmed | 1.48e-05 | 15 | 113 | 3 | 28190768 | ||
| Pubmed | 1.58e-05 | 244 | 113 | 7 | 29884807 | ||
| Pubmed | 1.58e-05 | 244 | 113 | 7 | 30349055 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.61e-05 | 163 | 113 | 6 | 22113938 | |
| Pubmed | Human Asf1 regulates the flow of S phase histones during replicational stress. | 1.81e-05 | 16 | 113 | 3 | 15664198 | |
| Pubmed | 1.91e-05 | 168 | 113 | 6 | 39066279 | ||
| Pubmed | H3-5 LRRC59 H3-4 H3-7 H3C15 HNRNPC H3C1 FBXO28 MACF1 H3-3A CTNNA1 XRCC6 | 2.03e-05 | 844 | 113 | 12 | 25963833 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SRSF6 HNRNPC PCF11 MSH6 DDX46 ARHGEF1 DDX23 MACF1 CTNNA1 XRCC6 | 2.12e-05 | 582 | 113 | 10 | 20467437 |
| Pubmed | H1-10 LRRC59 HNRNPC DDX46 PDE12 H3C1 MACF1 H3-3A CTNNA1 HDGFL2 XRCC6 | 2.12e-05 | 711 | 113 | 11 | 33022573 | |
| Pubmed | 2.25e-05 | 103 | 113 | 5 | 32744500 | ||
| Interaction | H3-3A interactions | CDKN1C H3-5 HIRIP3 XPC GPATCH8 MED1 H3-4 CDCA8 H3C15 MECP2 HNRNPC PRDM2 ZNF512B PHF2 MSH6 H3C1 RECQL5 MDC1 DDX23 H3-3A SCAF11 UHRF2 HDGFL2 XRCC6 TOP2B | 2.22e-13 | 749 | 110 | 25 | int:H3-3A |
| Interaction | H3C1 interactions | CDKN1C H1-10 H3-5 ANK2 LRRC59 XPC H3-4 CDCA8 H3-7 H3C15 MECP2 PRDM2 ZNF512B MSH6 TNRC18 H3C1 RECQL5 MDC1 POP1 H3-3A UHRF2 HDGFL2 XRCC6 TOP2B PDZD2 | 1.27e-11 | 901 | 110 | 25 | int:H3C1 |
| Interaction | H3C3 interactions | LRRC59 XPC MED1 CDCA8 H3-7 MECP2 PRDM2 ZNF512B PHF2 MSH6 RECQL5 MDC1 SCAF11 CHD6 UHRF2 HDGFL2 XRCC6 TOP2B | 1.93e-10 | 495 | 110 | 18 | int:H3C3 |
| Interaction | H2BC21 interactions | H1-10 H3-5 HIRIP3 CGAS XPC H3-4 CDCA8 H3-7 H3C15 MECP2 PRDM2 PHF2 MSH6 H3C1 FBXO28 MDC1 H3-3A SCAF11 XRCC6 TOP2B | 1.06e-09 | 696 | 110 | 20 | int:H2BC21 |
| Interaction | HMGA1 interactions | H1-10 H3-5 CGAS XPC H3-4 H3-7 H3C15 MECP2 TNRC18 H3C1 MDC1 H3-3A SCAF11 GOLGA3 XRCC6 TOP2B | 1.07e-09 | 419 | 110 | 16 | int:HMGA1 |
| Interaction | CBX3 interactions | XPC MED1 H3-4 SP110 CDCA8 H3C15 MECP2 AHDC1 NECAP1 ZNF512B H3C1 MDC1 C1orf52 MACF1 H3-3A UHRF2 HDGFL2 XRCC6 TOP2B | 1.99e-09 | 646 | 110 | 19 | int:CBX3 |
| Interaction | CENPA interactions | H1-10 HIRIP3 XPC CDCA8 H3-7 MECP2 PRDM2 ZNF512B PHF2 MSH6 H3-3A CHD6 HDGFL2 XRCC6 TOP2B | 2.14e-09 | 377 | 110 | 15 | int:CENPA |
| Interaction | H2AX interactions | H3-5 SRSF6 HIRIP3 XPC GPATCH8 H3-4 H3-7 H3C15 HNRNPC MSH6 TNRC18 H3C1 MDC1 DDX23 H3-3A UHRF2 HDGFL2 XRCC6 | 3.41e-09 | 593 | 110 | 18 | int:H2AX |
| Interaction | CHD4 interactions | H1-10 PPAN H3-5 SRSF6 LAMC3 GPATCH8 H3-4 H3C15 MECP2 HNRNPC ZNF512B MSH6 DDX46 H3C1 MDC1 DDX23 H3-3A SCAF11 HDGFL2 GOLGA3 XRCC6 TOP2B | 5.96e-09 | 938 | 110 | 22 | int:CHD4 |
| Interaction | HMGN5 interactions | 1.23e-08 | 154 | 110 | 10 | int:HMGN5 | |
| Interaction | H2BC8 interactions | HIRIP3 XPC H3-4 CDCA8 H3C15 MECP2 ZNF512B PHF2 MSH6 RECQL5 MDC1 C1orf52 SCAF11 CHD6 HDGFL2 XRCC6 TOP2B | 1.47e-08 | 576 | 110 | 17 | int:H2BC8 |
| Interaction | H1-0 interactions | H1-10 H3-5 CGAS WSB2 H3-4 H3C15 NECAP1 H3C1 FBXO28 POP1 H3-3A PLCE1 | 1.59e-08 | 256 | 110 | 12 | int:H1-0 |
| Interaction | SMC5 interactions | H1-10 H3-5 SRSF6 LRRC59 MED1 H3-4 CDCA8 H3C15 MECP2 HNRNPC ZNF512B PCF11 PHF2 DDX46 H3C1 RECQL5 MDC1 H3-3A SCAF11 HDGFL2 XRCC6 TOP2B | 1.89e-08 | 1000 | 110 | 22 | int:SMC5 |
| Interaction | XRCC6 interactions | EPS8 LRRC59 XPC MED1 MECP2 ZNF512B PCF11 PHF2 MSH6 TNRC18 DDX46 THRA H3C1 MDC1 H3-3A SCAF11 CTNNA1 UHRF2 HDGFL2 XRCC6 TOP2B | 2.59e-08 | 928 | 110 | 21 | int:XRCC6 |
| Interaction | XPC interactions | 2.84e-08 | 168 | 110 | 10 | int:XPC | |
| Interaction | PARP1 interactions | IRF2BP2 H3-5 XPC MED1 H3-4 CDCA8 H3C15 MECP2 PRDM2 NECAP1 ZNF512B PHF2 MSH6 THRA H3C1 RECQL5 POP1 H3-3A SCAF11 CHD6 CTNNA1 UHRF2 HDGFL2 XRCC6 TOP2B | 3.14e-08 | 1316 | 110 | 25 | int:PARP1 |
| Interaction | PARP2 interactions | 3.43e-08 | 128 | 110 | 9 | int:PARP2 | |
| Interaction | VRK1 interactions | H1-10 SRSF6 H3-4 MECP2 HNRNPC PCF11 H3C1 FBXO28 MDC1 H3-3A XRCC6 TOP2B | 3.81e-08 | 277 | 110 | 12 | int:VRK1 |
| Interaction | NSD2 interactions | SRSF6 H3-4 MECP2 NECAP1 ZNF512B DDX46 H3C1 MDC1 H3-3A UHRF2 GOLGA3 XRCC6 | 3.97e-08 | 278 | 110 | 12 | int:NSD2 |
| Interaction | DDX23 interactions | SRSF6 LRRC59 XPC GPATCH8 MECP2 ZNF512B PHF2 MSH6 DDX46 RECQL5 DDX23 H3-3A SCAF11 HDGFL2 TOP2B | 5.36e-08 | 480 | 110 | 15 | int:DDX23 |
| Interaction | H2AC14 interactions | 9.50e-08 | 144 | 110 | 9 | int:H2AC14 | |
| Interaction | H1-4 interactions | H3-5 HIRIP3 LRRC59 GPATCH8 H3-4 H3-7 H3C15 HNRNPC ZNF512B TNRC18 H3C1 EFCAB12 POP1 MACF1 H3-3A SCAF11 TOP2B | 9.70e-08 | 656 | 110 | 17 | int:H1-4 |
| Interaction | H2AC4 interactions | H1-10 ACTR8 H3-5 HIRIP3 XPC H3-4 H3-7 H3C15 HNRNPC H3C1 POP1 DDX23 H3-3A SCAF11 XRCC6 | 1.06e-07 | 506 | 110 | 15 | int:H2AC4 |
| Interaction | CHAMP1 interactions | 1.20e-07 | 148 | 110 | 9 | int:CHAMP1 | |
| Interaction | SET interactions | PPAN HIRIP3 H3-4 SP110 CDCA8 H3C15 MECP2 MEOX2 H3C1 DDX23 H3-3A XRCC6 | 1.35e-07 | 311 | 110 | 12 | int:SET |
| Interaction | H3-4 interactions | H1-10 H3-5 HIRIP3 H3-4 H3C15 AHDC1 PRDM2 PHF2 H3C1 ARHGEF1 POP1 AFF1 H3-3A CHD6 | 1.55e-07 | 448 | 110 | 14 | int:H3-4 |
| Interaction | SSRP1 interactions | SRSF6 HIRIP3 XPC H3C15 MECP2 HNRNPC PCF11 PHF2 MSH6 H3C1 DDX23 H3-3A SCAF11 UHRF2 HDGFL2 XRCC6 TOP2B | 1.79e-07 | 685 | 110 | 17 | int:SSRP1 |
| Interaction | H3C15 interactions | 2.02e-07 | 207 | 110 | 10 | int:H3C15 | |
| Interaction | PHF2 interactions | 2.29e-07 | 78 | 110 | 7 | int:PHF2 | |
| Interaction | ATRX interactions | ANK2 HIRIP3 CDCA8 MECP2 ZNF512B DDX46 H3C1 H3-3A ANO7 UHRF2 XRCC6 | 2.41e-07 | 267 | 110 | 11 | int:ATRX |
| Interaction | MACROH2A2 interactions | 2.41e-07 | 211 | 110 | 10 | int:MACROH2A2 | |
| Interaction | NUMA1 interactions | H1-10 LRRC59 H3C15 PRDM2 NECAP1 H3C1 ARHGEF1 FBXO28 MDC1 MACF1 H3-3A UHRF2 XRCC6 TOP2B | 2.70e-07 | 469 | 110 | 14 | int:NUMA1 |
| Interaction | NSD1 interactions | 2.89e-07 | 119 | 110 | 8 | int:NSD1 | |
| Interaction | MLLT1 interactions | 3.73e-07 | 123 | 110 | 8 | int:MLLT1 | |
| Interaction | CBX1 interactions | H3-4 SP110 CDCA8 H3C15 MECP2 AHDC1 H3C1 H3-3A HDGFL2 XRCC6 TOP2B | 5.11e-07 | 288 | 110 | 11 | int:CBX1 |
| Interaction | MEN1 interactions | H1-10 ACTR8 PPAN SRSF6 XPC MED1 H3-4 AHDC1 HNRNPC ZNF512B PCF11 DDX46 H3C1 ZNF608 MDC1 POP1 DDX23 H3-3A SCAF11 TOP2B | 6.66e-07 | 1029 | 110 | 20 | int:MEN1 |
| Interaction | CDK11B interactions | 7.28e-07 | 183 | 110 | 9 | int:CDK11B | |
| Interaction | SUPT16H interactions | H3-5 XPC MED1 H3C15 MECP2 MSH6 H3C1 DDX23 H3-3A ANO7 UHRF2 XRCC6 TOP2B | 8.77e-07 | 442 | 110 | 13 | int:SUPT16H |
| Interaction | THRAP3 interactions | SRSF6 LRRC59 MED1 H3C15 MECP2 HNRNPC THRA H3C1 MDC1 DDX23 H3-3A UHRF2 XRCC6 | 8.99e-07 | 443 | 110 | 13 | int:THRAP3 |
| Interaction | H2BC9 interactions | H1-10 H3-5 HIRIP3 TRO GPATCH8 H3-4 H3-7 H3C15 TNRC18 H3C1 MDC1 H3-3A HDGFL2 | 9.70e-07 | 446 | 110 | 13 | int:H2BC9 |
| Interaction | ZNF330 interactions | H1-10 XPC GPATCH8 CDCA8 MECP2 HNRNPC MEOX2 ZNF512B PHF2 MSH6 RECQL5 XRCC6 TOP2B | 9.70e-07 | 446 | 110 | 13 | int:ZNF330 |
| Interaction | HMGA2 interactions | 1.00e-06 | 140 | 110 | 8 | int:HMGA2 | |
| Interaction | ASF1A interactions | 1.10e-06 | 249 | 110 | 10 | int:ASF1A | |
| Interaction | PRC1 interactions | H1-10 ACTR8 PPAN H3-5 SRSF6 CGAS CDCA8 H3C15 MECP2 HNRNPC DDX46 H3C1 BTK MDC1 POP1 DDX23 XRCC6 TOP2B PDZD2 | 1.23e-06 | 973 | 110 | 19 | int:PRC1 |
| Interaction | RAD18 interactions | H1-10 HIRIP3 XPC SP110 H3C15 H3C1 POP1 DDX23 H3-3A SCAF11 CTNNA1 HDGFL2 TOP2B | 1.27e-06 | 457 | 110 | 13 | int:RAD18 |
| Interaction | ZNF512B interactions | 1.29e-06 | 196 | 110 | 9 | int:ZNF512B | |
| Interaction | MACROH2A1 interactions | VCX2 SRSF6 HIRIP3 CGAS XPC H3-4 MECP2 NECAP1 MSH6 H3C1 H3-3A HDGFL2 XRCC6 | 1.30e-06 | 458 | 110 | 13 | int:MACROH2A1 |
| Interaction | MECP2 interactions | SRSF6 LRRC59 XPC GPATCH8 MED1 H3C15 MECP2 AHDC1 HNRNPC ZNF512B PCF11 PHF2 MSH6 DDX46 H3C1 POP1 DDX23 MACF1 H3-3A CHD6 XRCC6 TOP2B | 1.46e-06 | 1287 | 110 | 22 | int:MECP2 |
| Interaction | NUP43 interactions | H1-10 XPC GPATCH8 CDCA8 MECP2 AHDC1 PRDM2 PHF2 ZNF608 RECQL5 MDC1 TOX3 CHD6 TOP2B PDZD2 | 1.54e-06 | 625 | 110 | 15 | int:NUP43 |
| Interaction | CHD2 interactions | 1.60e-06 | 66 | 110 | 6 | int:CHD2 | |
| Interaction | SRPK2 interactions | PPAN SRSF6 HIRIP3 GPATCH8 HNRNPC PNMA8B PCF11 DDX46 EFCAB12 RECQL5 MDC1 POP1 DDX23 MACF1 SCAF11 TOP2B | 1.73e-06 | 717 | 110 | 16 | int:SRPK2 |
| Interaction | SNRNP40 interactions | SRSF6 XPC GPATCH8 BCL9 MECP2 AHDC1 HNRNPC ZNF608 RECQL5 MDC1 POP1 DDX23 SCAF11 HDGFL2 TOP2B | 1.95e-06 | 637 | 110 | 15 | int:SNRNP40 |
| Interaction | H2BC5 interactions | 1.99e-06 | 331 | 110 | 11 | int:H2BC5 | |
| Interaction | TOP2B interactions | 2.00e-06 | 266 | 110 | 10 | int:TOP2B | |
| Interaction | SUZ12 interactions | H1-10 ACTR8 SRSF6 CGAS H3-4 AHDC1 NECAP1 ZNF512B PHF2 H3C1 DDX23 H3-3A SCAF11 CTNNA1 UHRF2 | 2.23e-06 | 644 | 110 | 15 | int:SUZ12 |
| Interaction | CIT interactions | H1-10 PPAN H3-5 SRSF6 CGAS LRRC59 MED1 CDCA8 H3C15 HNRNPC PHF2 MSH6 DDX46 MDC1 POP1 DDX23 MACF1 SCAF11 CTNNA1 UHRF2 HDGFL2 XRCC6 TOP2B | 2.88e-06 | 1450 | 110 | 23 | int:CIT |
| Interaction | AFF4 interactions | 3.21e-06 | 115 | 110 | 7 | int:AFF4 | |
| Interaction | CUL7 interactions | H1-10 PPAN H3-5 SRSF6 LRRC59 SP110 H3C15 HNRNPC MSH6 DDX46 MDC1 DDX23 MACF1 CTNNA1 GOLGA3 XRCC6 TOP2B | 3.23e-06 | 845 | 110 | 17 | int:CUL7 |
| Interaction | H2AC13 interactions | 3.42e-06 | 75 | 110 | 6 | int:H2AC13 | |
| Interaction | PHF3 interactions | 3.81e-06 | 118 | 110 | 7 | int:PHF3 | |
| Interaction | H2AC12 interactions | 3.81e-06 | 118 | 110 | 7 | int:H2AC12 | |
| Interaction | BRD2 interactions | H1-10 ACTR8 MED1 MECP2 PHF2 H3C1 VANGL1 MDC1 DDX23 H3-3A HDGFL2 TOP2B | 3.98e-06 | 429 | 110 | 12 | int:BRD2 |
| Interaction | CSNK2A1 interactions | PPAN HIRIP3 LRRC59 MECP2 HNRNPC MEOX1 MEOX2 MSH6 FBXO28 MDC1 POP1 MACF1 H3-3A CTNNA1 OCLN HDGFL2 XRCC6 BRMS1 | 4.06e-06 | 956 | 110 | 18 | int:CSNK2A1 |
| Interaction | MYH10 interactions | XPC H3C15 MECP2 HNRNPC ZNF512B MSH6 H3C1 DDX23 GOLGA3 XRCC6 TOP2B | 4.35e-06 | 359 | 110 | 11 | int:MYH10 |
| Interaction | H1-3 interactions | 4.44e-06 | 291 | 110 | 10 | int:H1-3 | |
| Interaction | DHX8 interactions | SRSF6 GPATCH8 MECP2 HNRNPC PCF11 DDX46 DDX23 H3-3A SCAF11 XRCC6 | 4.58e-06 | 292 | 110 | 10 | int:DHX8 |
| Interaction | DNAJC8 interactions | 4.80e-06 | 230 | 110 | 9 | int:DNAJC8 | |
| Interaction | CBX2 interactions | 5.89e-06 | 126 | 110 | 7 | int:CBX2 | |
| Interaction | TRRAP interactions | IRF2BP2 H3-5 SRSF6 HIRIP3 PPFIA3 MED1 H3-4 NUDT13 MECP2 ZNF512B H3C1 MDC1 DDX23 H3-3A CHD6 XRCC6 | 5.97e-06 | 790 | 110 | 16 | int:TRRAP |
| Interaction | C1orf174 interactions | 6.28e-06 | 48 | 110 | 5 | int:C1orf174 | |
| Interaction | NCL interactions | H1-10 PPAN H3-5 H3-4 H3C15 MECP2 NECAP1 MSH6 RECQL5 MDC1 DDX23 H3-3A UHRF2 HDGFL2 XRCC6 TOP2B | 6.77e-06 | 798 | 110 | 16 | int:NCL |
| Interaction | USF1 interactions | 7.10e-06 | 85 | 110 | 6 | int:USF1 | |
| Interaction | GATAD1 interactions | 7.62e-06 | 131 | 110 | 7 | int:GATAD1 | |
| Interaction | OBSL1 interactions | H1-10 PPAN H3-5 SRSF6 LRRC59 CDCA8 H3C15 HNRNPC DDX46 MDC1 POP1 DDX23 MACF1 CTNNA1 GOLGA3 XRCC6 TOP2B | 7.67e-06 | 902 | 110 | 17 | int:OBSL1 |
| Interaction | DOT1L interactions | H1-10 PPAN SRSF6 LRRC59 XPC H3-4 AHDC1 ZNF512B PCF11 DDX46 MDC1 POP1 AFF1 H3-3A SCAF11 TOP2B | 7.80e-06 | 807 | 110 | 16 | int:DOT1L |
| Interaction | CSNK2B interactions | EPS8 PPAN SRSF6 HIRIP3 LRRC59 XPC SP110 MECP2 PHF2 H3-3A OCLN HDGFL2 TOP2B NOTCH3 | 7.80e-06 | 625 | 110 | 14 | int:CSNK2B |
| Interaction | KMT2A interactions | 8.66e-06 | 314 | 110 | 10 | int:KMT2A | |
| Interaction | LOC102724334 interactions | 8.84e-06 | 134 | 110 | 7 | int:LOC102724334 | |
| Interaction | DNAJC17 interactions | 8.84e-06 | 134 | 110 | 7 | int:DNAJC17 | |
| Interaction | EHMT2 interactions | 8.90e-06 | 315 | 110 | 10 | int:EHMT2 | |
| Interaction | SETD2 interactions | 9.28e-06 | 135 | 110 | 7 | int:SETD2 | |
| Interaction | RBM5 interactions | 9.28e-06 | 135 | 110 | 7 | int:RBM5 | |
| Interaction | DNMT1 interactions | 1.07e-05 | 254 | 110 | 9 | int:DNMT1 | |
| Interaction | HMGB3 interactions | 1.12e-05 | 92 | 110 | 6 | int:HMGB3 | |
| Interaction | CEBPA interactions | IRF2BP2 MED1 BCL9 SP110 MECP2 AHDC1 HNRNPC PRDM2 PCF11 PHF2 MSH6 TNRC18 C1orf52 DDX23 MACF1 H3-3A UHRF2 HDGFL2 XRCC6 TOP2B | 1.19e-05 | 1245 | 110 | 20 | int:CEBPA |
| Interaction | H2BC4 interactions | 1.25e-05 | 259 | 110 | 9 | int:H2BC4 | |
| Interaction | BPTF interactions | 1.26e-05 | 197 | 110 | 8 | int:BPTF | |
| Interaction | REXO4 interactions | 1.33e-05 | 261 | 110 | 9 | int:REXO4 | |
| Interaction | DPF3 interactions | 1.35e-05 | 95 | 110 | 6 | int:DPF3 | |
| Interaction | ADNP interactions | 1.36e-05 | 199 | 110 | 8 | int:ADNP | |
| Interaction | TAF15 interactions | SRSF6 H3-4 MECP2 HNRNPC DDX46 H3C1 DDX23 ANO7 SCAF11 XRCC6 TOP2B | 1.45e-05 | 408 | 110 | 11 | int:TAF15 |
| Interaction | CHD3 interactions | H1-10 SRSF6 LRRC59 HNRNPC ZNF512B MSH6 DDX46 H3C1 DDX23 H3-3A SCAF11 CHD6 UHRF2 XRCC6 TOP2B | 1.55e-05 | 757 | 110 | 15 | int:CHD3 |
| Interaction | H1-2 interactions | H1-10 PPAN H3-5 SRSF6 ANK2 H3-4 H3-7 H3C15 NECAP1 H3C1 EFCAB12 POP1 H3-3A SP140 | 1.59e-05 | 666 | 110 | 14 | int:H1-2 |
| Interaction | KDM1B interactions | 1.61e-05 | 58 | 110 | 5 | int:KDM1B | |
| Interaction | CENPC interactions | 1.61e-05 | 98 | 110 | 6 | int:CENPC | |
| Interaction | BAZ1B interactions | 1.63e-05 | 204 | 110 | 8 | int:BAZ1B | |
| Interaction | H2AC18 interactions | 1.69e-05 | 148 | 110 | 7 | int:H2AC18 | |
| Interaction | SMARCA5 interactions | PPAN CGAS MECP2 HNRNPC NECAP1 ZNF512B H3C1 H3-3A UHRF2 GOLGA3 XRCC6 | 1.70e-05 | 415 | 110 | 11 | int:SMARCA5 |
| Interaction | NASP interactions | 1.81e-05 | 207 | 110 | 8 | int:NASP | |
| Interaction | LIG3 interactions | 1.81e-05 | 207 | 110 | 8 | int:LIG3 | |
| GeneFamily | Histones | 5.66e-07 | 116 | 76 | 7 | 864 | |
| GeneFamily | Variable charge X/Y family | 1.41e-06 | 6 | 76 | 3 | 368 | |
| GeneFamily | PHD finger proteins | 5.60e-04 | 90 | 76 | 4 | 88 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | KIF21B SRSF6 ARHGEF18 POU4F1 XPC POU6F1 MED1 SP110 HNRNPC PRDM2 PCF11 IFNG MSH6 DDX46 THRA ARHGEF1 BTK SCAF11 ALOX5 TOP2B SP140 | 3.00e-07 | 1394 | 110 | 21 | M9585 |
| Coexpression | GSE19512_NAUTRAL_VS_INDUCED_TREG_UP | 1.88e-06 | 197 | 110 | 8 | M8361 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 1.88e-06 | 197 | 110 | 8 | M9916 | |
| Coexpression | TRAVAGLINI_LUNG_PERICYTE_CELL | 8.79e-06 | 114 | 110 | 6 | M41678 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | VCX3A CGAS SP110 CDCA8 H3C15 TNRC18 PDE12 THRA AFF1 TRIM50 CTNNA1 VCX PLCE1 | 1.52e-05 | 746 | 110 | 13 | M40863 |
| Coexpression | GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN | 1.83e-05 | 194 | 110 | 7 | M5767 | |
| Coexpression | SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP | 1.98e-05 | 356 | 110 | 9 | M41052 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP | 2.22e-05 | 200 | 110 | 7 | M9770 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 7.58e-05 | 167 | 110 | 6 | M361 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-08 | 184 | 112 | 8 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-07 | 177 | 112 | 7 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-07 | 177 | 112 | 7 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-07 | 183 | 112 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-07 | 184 | 112 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.94e-07 | 193 | 112 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-06 | 154 | 112 | 6 | e3a8a1e63ab345de62bd2e5e54342b00f04ae422 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-06 | 156 | 112 | 6 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-06 | 157 | 112 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 165 | 112 | 6 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 165 | 112 | 6 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.99e-06 | 166 | 112 | 6 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-06 | 173 | 112 | 6 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-06 | 173 | 112 | 6 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-06 | 174 | 112 | 6 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-06 | 175 | 112 | 6 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-06 | 175 | 112 | 6 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.77e-06 | 177 | 112 | 6 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.98e-06 | 183 | 112 | 6 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.20e-06 | 184 | 112 | 6 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.20e-06 | 184 | 112 | 6 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.20e-06 | 184 | 112 | 6 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Pericyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-06 | 185 | 112 | 6 | 0e26a71fea526ebfe3b2d1c8d0d6d9b70282bbe9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-06 | 185 | 112 | 6 | b3320b794b22e654a33f28b575c9f00023baf5f0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 187 | 112 | 6 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 187 | 112 | 6 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 189 | 112 | 6 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 190 | 112 | 6 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 192 | 112 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 192 | 112 | 6 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 197 | 112 | 6 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 112 | 6 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 198 | 112 | 6 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 200 | 112 | 6 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.16e-05 | 200 | 112 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 200 | 112 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 200 | 112 | 6 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 4.13e-05 | 152 | 112 | 5 | 4f690aed23338687bdefc47e8a2f3d1fdb2b6447 | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 155 | 112 | 5 | 550e7e7e52829244ead829e5be010bfdc71e2ba5 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 5.43e-05 | 161 | 112 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 162 | 112 | 5 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 162 | 112 | 5 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 162 | 112 | 5 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.10e-05 | 165 | 112 | 5 | 953c8242a81a39ade63ac8e5b34fe58575771746 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | 2d23b4cee060f8adddc430c1c10d4e25205b4af6 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | ecaf08e8e0b54d1c97a02bc1f65409fd43d68227 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | ad6af6609acf158cb79e45ee7ca9af332be3c40c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 7.03e-05 | 170 | 112 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 7.23e-05 | 171 | 112 | 5 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.28e-05 | 176 | 112 | 5 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.28e-05 | 176 | 112 | 5 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.50e-05 | 177 | 112 | 5 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-05 | 177 | 112 | 5 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.50e-05 | 177 | 112 | 5 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-05 | 177 | 112 | 5 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.73e-05 | 178 | 112 | 5 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.96e-05 | 179 | 112 | 5 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.96e-05 | 179 | 112 | 5 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.96e-05 | 179 | 112 | 5 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.20e-05 | 180 | 112 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 9.44e-05 | 181 | 112 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 9.44e-05 | 181 | 112 | 5 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 9.69e-05 | 182 | 112 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 183 | 112 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 9.94e-05 | 183 | 112 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 183 | 112 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 184 | 112 | 5 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.02e-04 | 184 | 112 | 5 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 185 | 112 | 5 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 185 | 112 | 5 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-04 | 185 | 112 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 185 | 112 | 5 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 185 | 112 | 5 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 185 | 112 | 5 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-04 | 185 | 112 | 5 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 1.05e-04 | 185 | 112 | 5 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 186 | 112 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 1.07e-04 | 186 | 112 | 5 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 112 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 187 | 112 | 5 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 112 | 5 | f1e9877d859369b862d4a559ec9ab9be74a67a96 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 112 | 5 | 3ffbd50b49059dcd3e23c5ac01901e4352142446 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 187 | 112 | 5 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-04 | 188 | 112 | 5 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-small_pre-B-II_cell|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 190 | 112 | 5 | f49ceda3622cf079cffde9c9a9e3d0380c571d39 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-04 | 190 | 112 | 5 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 190 | 112 | 5 | ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 191 | 112 | 5 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 191 | 112 | 5 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 3.00e-06 | 181 | 111 | 8 | 1791_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A | 5.41e-06 | 196 | 111 | 8 | 3121_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 5.62e-06 | 197 | 111 | 8 | 3187_UP | |
| Drug | hydroxyurea | XPC CDCA8 H3-7 IFNG MSH6 RECQL5 MDC1 H3-3A ALOX5 XRCC6 TOP2B | 9.51e-06 | 436 | 111 | 11 | CID000003657 |
| Disease | Encephalopathies | 1.24e-04 | 27 | 106 | 3 | C0085584 | |
| Disease | Respiratory Syncytial Virus Infections | 1.27e-04 | 5 | 106 | 2 | C0035235 | |
| Disease | cholangiocarcinoma, sclerosing cholangitis | 1.27e-04 | 5 | 106 | 2 | EFO_0004268, EFO_0005221 | |
| Disease | Malignant neoplasm of breast | ANK2 SP110 CRX IFNG MSH6 LMF2 BTK POP1 TOX3 AFF1 MACF1 OCLN NOTCH3 | 1.27e-04 | 1074 | 106 | 13 | C0006142 |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 1.87e-04 | 328 | 106 | 7 | EFO_0008377, EFO_0008378 | |
| Disease | GLIOMA SUSCEPTIBILITY 1 | 1.90e-04 | 6 | 106 | 2 | C2750850 | |
| Disease | response to anticonvulsant | 2.55e-04 | 85 | 106 | 4 | GO_0036277 | |
| Disease | lung cancer (implicated_via_orthology) | 4.53e-04 | 9 | 106 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) | 5.65e-04 | 10 | 106 | 2 | C1834752 | |
| Disease | Mycobacterium tuberculosis, susceptibility to | 5.65e-04 | 10 | 106 | 2 | cv:C1834752 | |
| Disease | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO | 5.65e-04 | 10 | 106 | 2 | 607948 | |
| Disease | Adenocarcinoma of lung (disorder) | 9.05e-04 | 206 | 106 | 5 | C0152013 | |
| Disease | ovarian neoplasm | 1.41e-03 | 134 | 106 | 4 | C0919267 | |
| Disease | Cerebrovascular accident | 1.46e-03 | 62 | 106 | 3 | C0038454 | |
| Disease | Malignant neoplasm of ovary | 1.53e-03 | 137 | 106 | 4 | C1140680 | |
| Disease | colorectal cancer, inflammatory bowel disease | 2.10e-03 | 19 | 106 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | Glioblastoma | 2.92e-03 | 79 | 106 | 3 | C0017636 | |
| Disease | Renal glomerular disease | 3.08e-03 | 23 | 106 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.08e-03 | 23 | 106 | 2 | C4521256 | |
| Disease | Morbilliform Drug Reaction | 3.08e-03 | 23 | 106 | 2 | C0406537 | |
| Disease | generalized anxiety disorder | 3.08e-03 | 23 | 106 | 2 | EFO_1001892 | |
| Disease | Drug Eruptions | 3.08e-03 | 23 | 106 | 2 | C0011609 | |
| Disease | Epilepsy, Cryptogenic | 3.25e-03 | 82 | 106 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.25e-03 | 82 | 106 | 3 | C0751111 | |
| Disease | Aura | 3.25e-03 | 82 | 106 | 3 | C0236018 | |
| Disease | Giant Cell Glioblastoma | 3.48e-03 | 84 | 106 | 3 | C0334588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKSPRNKDGRGSEKS | 31 | Q8TAA9 | |
| KRRPASGDDLSAKKS | 66 | Q92564 | |
| GNRRSDEPAKTKKGL | 251 | Q92888 | |
| GKECDSPKKRGRSRS | 141 | Q6ZSZ5 | |
| KAKRPLRGSSSQKAG | 51 | A0A1B0GTR3 | |
| KAKRPLRGSSSQKAG | 51 | P0DPH9 | |
| RNGSLKPGSSHRKTK | 171 | Q06187 | |
| AKATADRKSASKPIG | 436 | Q9H981 | |
| APGDTGVDKRDRKKS | 101 | Q6NUI1 | |
| QSSSKPGRGRRKKVD | 1226 | Q5TGY3 | |
| PAKSAGGCRNKAEKR | 41 | Q8N6N3 | |
| SPGDKKSKNRSTRGK | 31 | Q8IYB7 | |
| FGPARKSGSRQKKSA | 51 | Q8N884 | |
| RSQGPGKSKRTDKKT | 456 | Q6NXP0 | |
| SRGLQRAPEKTKGKV | 936 | O60312 | |
| KKSGKSGPTRHRAQQ | 621 | Q9Y2G4 | |
| GSKGNSLKRSKSIRP | 251 | Q96S21 | |
| RKDSSGTSKRKSQQP | 1616 | Q9H0J4 | |
| APAKGRAGRSKRTEQ | 381 | Q16625 | |
| NRGKPEGSSKARKER | 161 | P50221 | |
| FNGSSQRRKRPKKSD | 16 | Q01484 | |
| SKKRKAGASAGASQG | 676 | Q6IWH7 | |
| NGGEKKRKRTSIAAP | 351 | Q01851 | |
| GGPQGERKNRSSKKS | 376 | Q9BW71 | |
| AEPKVNRGKAGVKRS | 86 | P07910 | |
| ATRGRKNRSSGKTPE | 1391 | Q14676 | |
| GATPSAEGKRKRNKS | 206 | Q86UL8 | |
| SQKKRGEARGKSEPI | 1286 | Q6PRD1 | |
| ANQAPKSKSGSRPRK | 221 | Q96AG4 | |
| QTARKSTGGKAPRKQ | 6 | P84243 | |
| STGGKAPRKQLATKA | 11 | P84243 | |
| KAAPGAAGSRRADKK | 146 | Q92522 | |
| AKLTGPGDKDRRNKR | 806 | O75145 | |
| RTQSIQGKGKGKRSS | 151 | Q53HL2 | |
| QGKGKGKRSSRANTV | 156 | Q53HL2 | |
| QTARKSTGGKAPRKQ | 6 | Q5TEC6 | |
| STGGKAPRKQLATKA | 11 | Q5TEC6 | |
| RKKNKSSAPADSERG | 716 | Q9UKJ3 | |
| QTARKSTGGKAPRKQ | 6 | Q6NXT2 | |
| STGGKAPRKQLATKA | 11 | Q6NXT2 | |
| AAKKSRKSRPNASGG | 91 | Q6L8Q7 | |
| KNSPAGKSGKVRLRD | 126 | O15018 | |
| GTRPARKKFQKKGAS | 891 | O75037 | |
| PGLKAAQSGSKKSRR | 2051 | Q9UM47 | |
| AQSGSKKSRRPPGKA | 2056 | Q9UM47 | |
| FVGGEPSKKRKRRTS | 226 | Q14863 | |
| KTNRADPKKSASRPG | 3426 | O94854 | |
| QTARKSTGGKAPRKQ | 6 | Q16695 | |
| PAEAEKRSGGKRKSD | 156 | P50222 | |
| QTARKSTGGKAPRKQ | 6 | P68431 | |
| STGGKAPRKQLATKA | 11 | P68431 | |
| KDRKRSSLSPGRGKD | 101 | Q9BUQ8 | |
| SSLSPGRGKDFKSRK | 106 | Q9BUQ8 | |
| GNGSLKRKSSRKETP | 306 | P52701 | |
| TFGCAGERSKPKRQK | 456 | O94988 | |
| RGAAKTRKEPKGEAS | 1376 | Q08378 | |
| RSGQPTKKNVAGSKR | 171 | Q86X67 | |
| GGRKKKKAPSASDSD | 221 | Q7Z4V5 | |
| KQGTKPGRSSTRKRS | 466 | O94913 | |
| KREKRQKPGRASSDG | 916 | Q99575 | |
| PQNPSSRKKGRSKRA | 41 | Q9UI47 | |
| KKHTSKEPRRAGAAG | 446 | P0C671 | |
| NTNSKGPSNKKRGRS | 41 | P35221 | |
| FAKRKRSAPEKSSGD | 276 | P49918 | |
| AARTKSRKASKEQGP | 176 | Q8TD26 | |
| NGAKGKGKRERSISA | 91 | O00512 | |
| SGSGQNEESPRKRKK | 336 | Q9NVF7 | |
| APGDTGVDKRDRKKS | 101 | Q3MJ40 | |
| SSPNTVKRPTKKGRD | 321 | P11229 | |
| AELSPAAKTGKRKRS | 141 | P01579 | |
| DSKGGKQKRRPDALR | 186 | Q12929 | |
| SPGNKSKKTENRSRS | 106 | Q7L014 | |
| APGDTGVDKRDRKKS | 101 | A2RUR9 | |
| QSPSPKNESARGRKK | 831 | Q99590 | |
| GSKAVARTARKRKPS | 346 | Q7Z5L9 | |
| QAKARPAKRKAGTSP | 111 | O43186 | |
| KPGKRSRTPSNDGKS | 991 | Q15648 | |
| KEPLGSTNSEAKKRR | 626 | Q13029 | |
| KKRGRKPGSVVAAAA | 266 | P51608 | |
| GGAKKASSGLRRPEK | 86 | Q12947 | |
| SGPSKAKKTNAGIRR | 31 | Q12946 | |
| PAKATEAGKRKSSSQ | 11 | Q9NNX9 | |
| KRKGEAATRAKPSAA | 201 | Q93075 | |
| KPGRNARVKKESGSS | 746 | O75151 | |
| GRGAKKRKASGSENE | 1541 | Q02880 | |
| GEKRRPASQKDSGAA | 671 | Q9BU23 | |
| RKSSGFPKSVKSREQ | 521 | P09917 | |
| QKKGSKATPRSRPSA | 1181 | Q5HYW2 | |
| GKERKSRKSIFGNNP | 1691 | Q9P212 | |
| QAPTGSKAARGKKAR | 611 | Q9ULN7 | |
| QTARKSTGGKAPRKQ | 6 | Q71DI3 | |
| STGGKAPRKQLATKA | 11 | Q71DI3 | |
| SRSRSPKENGKGDIK | 276 | Q13247 | |
| RHKKKSLPGGTASSR | 291 | Q9HB58 | |
| KARAAVSPQKRKSDG | 231 | Q9HCU9 | |
| RGKGKARASQVKPGD | 331 | P08913 | |
| KKPVKASARAGSRTS | 606 | P51825 | |
| KTKGRPRAAASNEPK | 646 | P51825 | |
| SGGSSLAKGRASKKQ | 736 | O94762 | |
| GKTPLKNGSSCKRTN | 161 | Q96PU4 | |
| AQAGAKSRPKKREGV | 2741 | O15417 | |
| TKRKHDNEGSGSKRP | 541 | P12956 | |
| PAKATEAGKRKSSSQ | 11 | Q9H322 | |
| KGKKAASRGPNSVSE | 301 | Q12816 | |
| FPKTKDKSQGAQARR | 436 | Q9NQ55 | |
| RQGRKKPAGKSLASE | 691 | P38935 | |
| TSEKINKRSGPKRGR | 146 | Q7RTT4 | |
| NKRKRKTSDDGGDSP | 86 | Q9HAJ7 | |
| ERPCKSSKGNKRGRT | 111 | Q9HAH1 | |
| GGSPARREEKKRKAA | 371 | O60504 | |
| RAIGEKRAAPDSGKK | 226 | O15405 | |
| PAKATEAGKRKSSSQ | 11 | Q9H320 | |
| NKAPRATGRNSGKKR | 331 | Q96KM6 | |
| KPGKSQSSRGAKRDK | 191 | Q9ULD9 | |
| SDNGLKAGLGRSKSK | 286 | Q9ULC8 | |
| KAGLGRSKSKGSLDR | 291 | Q9ULC8 | |
| KRGKPGTRFTQSDRA | 551 | Q13342 | |
| SPDGKRKRKNGQCSL | 21 | P10827 | |
| RSSKNETKGRGSPKE | 71 | Q9NYS7 | |
| TFAKGTCRPSAKGKR | 371 | Q01831 | |
| NKGGRKKRSKPSSSE | 386 | Q01831 | |
| GKDLSGNKTRSCKAP | 186 | P0DMS9 | |
| IKGTASRKGKLNRSP | 366 | Q86XT4 | |
| NAAPLSSSAKKKGRE | 1386 | Q9Y6N6 | |
| ITNKKGGASKPRTAR | 166 | Q8NC96 |